Horimed, a Tianjin-based manufacturer of OCT imaging equipment, has reportedly raised “tens of millions” of renminbi in a recent financing round. The round was led by existing investor Tasly Capital, with contributions from Haihe Fund and Haitai Capital. The proceeds will be allocated to research and development, manufacturing, regulatory filings, and commercialization efforts.
The company specializes in the R&D, manufacturing, and sales of intravascular ultrasound (IVUS) equipment and catheters, optical coherence tomography (OCT) equipment and catheters, and an integrated dual catheter system for IVUS/OCT. Additionally, Horimed is developing a non-invasive blood flow reserve fraction (FFR) platform based on IVUS and OCT, single light source dual-mode OCT-NIRS technology that combines OCT and near-infrared spectroscopy, and intravascular laser plaque ablation technology.- Flcube.com
